APLICACION DE LA TECNOLOGIA DE MICROMATRICES DE ADN AL ESTUDIO DE LA ENDOMETRIOSIS

(especial para SIIC © Derechos reservados)
Las nuevas técnicas de investigación del genoma, así como las destinadas a extraer información de bases de datos permitirán avanzar en el diagnóstico y el tratamiento de la endometriosis.
eyster9.jpg Autor:
Kathleen m. Eyster
Columnista Experto de SIIC
Artículos publicados por Kathleen m. Eyster
Coautores
John D. Brannian*  Keith A. Hansen** 
Ph.D. University of South Dakota School of Medicine, Sioux Falls, SD*
MD University of South Dakota School of Medicine, Sioux Falls, SD**
Recepción del artículo
18 de Diciembre, 2003
Aprobación
11 de Junio, 2004
Primera edición
6 de Octubre, 2004
Segunda edición, ampliada y corregida
7 de Junio, 2021

Resumen
La endometriosis es una enfermedad muy difundida y debilitante. A pesar de las investigaciones realizadas, aún quedan muchas preguntas por responder. Por ejemplo, ¿por qué algunas mujeres tienen endometriosis y otras no ¿Es posible elaborar un método no invasivo para diagnosticar la endometriosis ¿Es posible elaborar tratamientos médicos para la endometriosis, que alivien el dolor, restauren la fertilidad y causen menos reacciones adversas ¿Las diferencias y similitudes en las propiedades invasivas del endometrio ectópico y del cáncer pueden ayudar a comprender ambas entidades Es fundamental la comprensión total de cómo funcionan y se comunican las células endometriales ectópicas y en qué se diferencian de las células eutópicas, para poder lograr las respuestas a las cuestiones anteriores. Una tecnología de evaluación global del genoma, como la de micromatrices de ADN, es una herramienta excelente para examinar las cuestiones planteadas por la endometriosis. Esta tecnología, junto con otras como el estudio del proteoma y la prospección informática de datos, permitirán avanzar en el diagnóstico y el tratamiento de la enfermedad.

Palabras clave
Endometriosis, micromatrices, endometrio, vimentina


Artículo completo

(castellano)
Extensión:  +/-8.27 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes

Abstract
Endometriosis is a widespread and debilitating disease. Despite intense research, a variety of questions remain unanswered. For example, why do some women get endometriosis and not others Can we develop a noninvasive method for diagnosis of endometriosis Can we develop medical treatments for endometriosis that relieve pain, restore fertility, and cause fewer adverse reactions Can the similarities and differences in the invasive properties of the ectopic endometrium and cancer provide insight into both of these diseases For each of these questions, a more thorough fundamental understanding of how eutopic endometrial cells function and communicate, and how ectopic endometrial cells differ from eutopic endometrial cells, will build the foundation to provide answers. A global genome-screening technology such as the DNA microarray is an excellent tool for examining the questions posed by endometriosis. DNA microarray analysis is beginning to be applied to the questions of endometriosis. This technology, along with other technologies such as proteomics and data mining, holds promise to advance diagnosis and treatment of this disease.

Key words
Endometriosis, microarray, endometrium, vimentin


Full text
(english)
para suscriptores/ assinantes

Clasificación en siicsalud
Artículos originales > Expertos del Mundo >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Medicina Reproductiva, Obstetricia y Ginecología
Relacionadas: Diagnóstico por Laboratorio



Comprar este artículo
Extensión: 8.27 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Bibliografía del artículo
  1. Speroff L, Glass RH, Kase NG, eds. Endometriosis. In: Clinical Gynecologic Endocrinology and Infertility, Sixth Edition. Baltimore: Lippincott, Williams, and Wilkins, 1999:1057-1073.
  2. Schenken RS. Endometriosis. In: Scott JR, Di Sain PJ, Hammond CB, Spellacy WN, eds. Danforth's Obstetrics and Gynecology, Eighth Edition. Baltimore: Lippincott, Williams, and Wilkin, 1999;669-675.
  3. Barbieri RL, Missmer S. Endometriosis and infertility: A cause-effect relationship Annals NY Acad Sci 2002;955:23-33.
  4. Guidice LC, Telles TL, Lobo S, Kao L. The molecular basis for implantation failure in endometriosis: On the road to discovery. Annals NY Acad Sci 2002;955:252-264.
  5. Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertility and Sterility 2002;77:1148-1155.
  6. Ota H, Igarashi S, Kato N, Tanaka T. Aberrant expression of glutathione peroxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis. Fertil Steril 2000;74:313-318.
  7. Tsudo T, Harada T, Iwabe T, Tanikawa M, Nagano Y, Ito M, et al. Altered gene expression and secretion of interleukin-6 in stromal cells derived from endometriotic tissues. Fertil Steril 2000;73:205-211.
  8. Mahnke JL, Dawood MY, Huang J-C. Vascular endothelial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis. Fertil Steril 2000;73:166-170.
  9. Sharpe-Timms K, Piva M, Ricke EA, Surewicz K, Zhang YL, Zimmer RL. Endometriotic lesions synthesize and secrete a haptoglobin-like protein. Biol Reprod 1998;58:988-994.
  10. Kokorine I, Eeckhout Y, Nisolle M, Courtoy PJ, Donnez J, Marbaix E. Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions. Fertil Steril 1997;68:246-251.
  11. Ota H, Igarashi S, Hatazawa J, Tanaka T. Immunohistochemical assessment of superoxide dismutase expression in the endometrium in endometriosis and adenomyosis. Fertil Steril 1999;72:129-134.
  12. Sharpe KL, Zimmer RL, Griffin WT, Penney LL. Polypeptides synthesized and released by human endometriosis differ from those of the uterine endometrium in cell and tissue explant culture. Fertil Steril 1993;60:839-851.
  13. Vaisse C, Atger M, Potier B, Milgrom E. Human placental protein 14 gene: sequence and characterization of a short duplication. DNA Cell Biol 1990;9:401-413.
  14. Mueller MD, Vigne J-L, Vaisse C, Taylor RN. Glycodelin: a pane in the implantation window. Semin Reprod Med 2000;18:289-298.
  15. Eyster KM, Boles AL, Brannian JD, Hansen KA. DNA microarray analysis of gene expression markers of endometriosis. Fertility and Sterility 2002;77:38-42.
  16. Kao LC, Tulac S, Lobo S, Imani B, Yang JP, Germeyer A, Osteen K, Taylor RN, Lessey BA, Giudice LC. Global gene profiling in human endometrium during the window of implantation. Endocrinology 2002;143:2119-2138.
  17. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, Osteen K, Lessey BA, Giudice LC. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 2003;144:2870-2881.
  18. Carson DD, Lagow E, Thathiah A, Al-Shami R, Farach-Carson MC, Vernon M, Yuan L, Fritz MA, Lessey BA. Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Mol Hum Reprod 2002;8:871-879.
  19. Borthwick JM, Charnock-Jones DS, Tom BD, Hull ML, Teirney R, Phillips SC, Smith SK. Determination of the transcript profile of human endometrium. Mol Hum Reprod 2003;9:19-33.
  20. Taylor RN, Lundeen SG, Guidice LC. Emerging role of genomics in endometriosis research. Fertility and Sterility 2002;78:694-698.
  21. Eyster KM, Lindahl R. Molecular medicine: A primer for clinicians. Part XII: DNA microarrays and their application to clinical medicine. South Dakota Journal of Medicine, 2001;2:57-61.
  22. Popovici RM, Kao L-C, Giudice LC. Discovery of new inducible genes in in vitro decidualized human endometrial stromal cells using microarray technology. Endocrinology 2000;141:3510-3513.
  23. Herrmann H, Aebi U. Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. Curr Opinion Cell Biol 2000;12:79-90.
  24. Correia I, Chu D, Chou Y-H, Goldman RD, Matsudaira P. Integrating the actin and vimentin cytoskeletons: adhesion-dependent formation of fimbrin-vimentin complexes in macrophages. J Cell Biol 1999;146:831-842.
  25. Klymkowsky MW. Intermediate filaments: new proteins, some answers, more questions. Curr Opin Cell Biol 1995;7:46-54.
  26. Cicatiello L, Ambrosino C, Coletta B, Scalona M, Sica V, Breesciani F,et al. Transcriptional activation of jun and actin genes by estrogen during mitogenic stimulation of rat uterine cells. J Steroid Biochem Molec Biol 1992;41:523-528.
  27. Weisinger G, Gavish M, Mazurika C, Zinder O. Transcription of actin, cyclophilin and glyceraldehyde phosphate dehydrogenase genes: tissue- and treatment-specificity. Biochim Biophys Acta 1999;1446:225-232.
  28. Knowles JT. Oestriol-stimulated synthesis of ribonucleic acid in the uterus of the immature rat. Biochem J 1978;170:181-183.
  29. Muller RE, Knowles JT. The synthesis of ribosomal RNA and ribosomal protein and their incorporation into ribosomes in the uterus of the oestrogen-stimulated immature rat. FEBS Lett 1984;174:253-257.
  30. Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil Steril 2001;75:1-10.
  31. Nothnick WB. Treating endometriosis as an autoimmune disease. Fertil Steril 2001;76:223-231.
  32. Oosterlynck DJ. Immunohistochemical characterization of leukocyte subpopulations in endometriotic lesions. Arch Gynecol Obstet 1993;253:1977-206.
  33. Nomiyama M, Hachisuga T, Sou H, Nakamura K, Matsumoto Y, Iwasaka T, et al. Local immune response in infertile patients with minimal endometriosis. Gynecol Obstet Invest 1997;44:32-37.
  34. Goldsby RA, Kindt TJ, Osborne BA. Organization and expression of immunoglobulin genes. In: Kuby Immunology, Fourth edition. New York: WH Freeman and Company, 2000:115-128.
  35. Bateman RH, Carruthers R, Hoyes JB, Jones C, Langridge JI, Millar A, Vissers JPC. A novel precursor ion discovery method on a hybrid quadrupole orthogonal acceleration time-of-flight (Q-Tof) mass spectrometer for studying protein phosphorylation. J Am Soc Mass Spec 2002;13:792-803.
  36. Petricoin EF III, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-577.

Título español
Resumen
 Palabras clave
 Bibliografía
 Artículo completo
(exclusivo a suscriptores)
 Autoevaluación
  Tema principal en SIIC Data Bases
 Especialidades

 English title
 Abstract
 Key words
Full text
(exclusivo a suscriptores)

Autor 
Artículos
Correspondencia

Patrocinio y reconocimiento
Imprimir esta página
 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618
Inicio/Home

Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008